purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncology Drug Discovery Services
1.2 Key Market Segments
1.2.1 Oncology Drug Discovery Services Segment by Type
1.2.2 Oncology Drug Discovery Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology Drug Discovery Services Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology Drug Discovery Services Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Drug Discovery Services Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology Drug Discovery Services Market Competitive Landscape
3.1 Global Oncology Drug Discovery Services Sales by Manufacturers (2019-2024)
3.2 Global Oncology Drug Discovery Services Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Drug Discovery Services Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Drug Discovery Services Sales Sites, Area Served, Product Type
3.6 Oncology Drug Discovery Services Market Competitive Situation and Trends
3.6.1 Oncology Drug Discovery Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Drug Discovery Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncology Drug Discovery Services Industry Chain Analysis
4.1 Oncology Drug Discovery Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology Drug Discovery Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncology Drug Discovery Services Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Drug Discovery Services Sales Market Share by Type (2019-2024)
6.3 Global Oncology Drug Discovery Services Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Drug Discovery Services Price by Type (2019-2024)
7 Oncology Drug Discovery Services Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Drug Discovery Services Market Sales by Application (2019-2024)
7.3 Global Oncology Drug Discovery Services Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Drug Discovery Services Sales Growth Rate by Application (2019-2024)
8 Oncology Drug Discovery Services Market Segmentation by Region
8.1 Global Oncology Drug Discovery Services Sales by Region
8.1.1 Global Oncology Drug Discovery Services Sales by Region
8.1.2 Global Oncology Drug Discovery Services Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Drug Discovery Services Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Drug Discovery Services Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Drug Discovery Services Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Drug Discovery Services Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Drug Discovery Services Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Charles River
9.1.1 Charles River Oncology Drug Discovery Services Basic Information
9.1.2 Charles River Oncology Drug Discovery Services Product Overview
9.1.3 Charles River Oncology Drug Discovery Services Product Market Performance
9.1.4 Charles River Business Overview
9.1.5 Charles River Oncology Drug Discovery Services SWOT Analysis
9.1.6 Charles River Recent Developments
9.2 Evotec
9.2.1 Evotec Oncology Drug Discovery Services Basic Information
9.2.2 Evotec Oncology Drug Discovery Services Product Overview
9.2.3 Evotec Oncology Drug Discovery Services Product Market Performance
9.2.4 Evotec Business Overview
9.2.5 Evotec Oncology Drug Discovery Services SWOT Analysis
9.2.6 Evotec Recent Developments
9.3 GE Healthcare Life Sciences
9.3.1 GE Healthcare Life Sciences Oncology Drug Discovery Services Basic Information
9.3.2 GE Healthcare Life Sciences Oncology Drug Discovery Services Product Overview
9.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Product Market Performance
9.3.4 GE Healthcare Life Sciences Oncology Drug Discovery Services SWOT Analysis
9.3.5 GE Healthcare Life Sciences Business Overview
9.3.6 GE Healthcare Life Sciences Recent Developments
9.4 GenScript
9.4.1 GenScript Oncology Drug Discovery Services Basic Information
9.4.2 GenScript Oncology Drug Discovery Services Product Overview
9.4.3 GenScript Oncology Drug Discovery Services Product Market Performance
9.4.4 GenScript Business Overview
9.4.5 GenScript Recent Developments
9.5 Horizon Discovery
9.5.1 Horizon Discovery Oncology Drug Discovery Services Basic Information
9.5.2 Horizon Discovery Oncology Drug Discovery Services Product Overview
9.5.3 Horizon Discovery Oncology Drug Discovery Services Product Market Performance
9.5.4 Horizon Discovery Business Overview
9.5.5 Horizon Discovery Recent Developments
9.6 TCG Lifesciences
9.6.1 TCG Lifesciences Oncology Drug Discovery Services Basic Information
9.6.2 TCG Lifesciences Oncology Drug Discovery Services Product Overview
9.6.3 TCG Lifesciences Oncology Drug Discovery Services Product Market Performance
9.6.4 TCG Lifesciences Business Overview
9.6.5 TCG Lifesciences Recent Developments
9.7 Zumutor
9.7.1 Zumutor Oncology Drug Discovery Services Basic Information
9.7.2 Zumutor Oncology Drug Discovery Services Product Overview
9.7.3 Zumutor Oncology Drug Discovery Services Product Market Performance
9.7.4 Zumutor Business Overview
9.7.5 Zumutor Recent Developments
9.8 ChemPartner
9.8.1 ChemPartner Oncology Drug Discovery Services Basic Information
9.8.2 ChemPartner Oncology Drug Discovery Services Product Overview
9.8.3 ChemPartner Oncology Drug Discovery Services Product Market Performance
9.8.4 ChemPartner Business Overview
9.8.5 ChemPartner Recent Developments
9.9 Aquila BioMedical
9.9.1 Aquila BioMedical Oncology Drug Discovery Services Basic Information
9.9.2 Aquila BioMedical Oncology Drug Discovery Services Product Overview
9.9.3 Aquila BioMedical Oncology Drug Discovery Services Product Market Performance
9.9.4 Aquila BioMedical Business Overview
9.9.5 Aquila BioMedical Recent Developments
9.10 Onconova
9.10.1 Onconova Oncology Drug Discovery Services Basic Information
9.10.2 Onconova Oncology Drug Discovery Services Product Overview
9.10.3 Onconova Oncology Drug Discovery Services Product Market Performance
9.10.4 Onconova Business Overview
9.10.5 Onconova Recent Developments
9.11 Vichem Chemie
9.11.1 Vichem Chemie Oncology Drug Discovery Services Basic Information
9.11.2 Vichem Chemie Oncology Drug Discovery Services Product Overview
9.11.3 Vichem Chemie Oncology Drug Discovery Services Product Market Performance
9.11.4 Vichem Chemie Business Overview
9.11.5 Vichem Chemie Recent Developments
9.12 GVK Biosciences
9.12.1 GVK Biosciences Oncology Drug Discovery Services Basic Information
9.12.2 GVK Biosciences Oncology Drug Discovery Services Product Overview
9.12.3 GVK Biosciences Oncology Drug Discovery Services Product Market Performance
9.12.4 GVK Biosciences Business Overview
9.12.5 GVK Biosciences Recent Developments
9.13 NuChem Therapeutics
9.13.1 NuChem Therapeutics Oncology Drug Discovery Services Basic Information
9.13.2 NuChem Therapeutics Oncology Drug Discovery Services Product Overview
9.13.3 NuChem Therapeutics Oncology Drug Discovery Services Product Market Performance
9.13.4 NuChem Therapeutics Business Overview
9.13.5 NuChem Therapeutics Recent Developments
9.14 Syncom
9.14.1 Syncom Oncology Drug Discovery Services Basic Information
9.14.2 Syncom Oncology Drug Discovery Services Product Overview
9.14.3 Syncom Oncology Drug Discovery Services Product Market Performance
9.14.4 Syncom Business Overview
9.14.5 Syncom Recent Developments
9.15 Envigo
9.15.1 Envigo Oncology Drug Discovery Services Basic Information
9.15.2 Envigo Oncology Drug Discovery Services Product Overview
9.15.3 Envigo Oncology Drug Discovery Services Product Market Performance
9.15.4 Envigo Business Overview
9.15.5 Envigo Recent Developments
9.16 DiverChim
9.16.1 DiverChim Oncology Drug Discovery Services Basic Information
9.16.2 DiverChim Oncology Drug Discovery Services Product Overview
9.16.3 DiverChim Oncology Drug Discovery Services Product Market Performance
9.16.4 DiverChim Business Overview
9.16.5 DiverChim Recent Developments
9.17 Aurora
9.17.1 Aurora Oncology Drug Discovery Services Basic Information
9.17.2 Aurora Oncology Drug Discovery Services Product Overview
9.17.3 Aurora Oncology Drug Discovery Services Product Market Performance
9.17.4 Aurora Business Overview
9.17.5 Aurora Recent Developments
9.18 HD Biosciences
9.18.1 HD Biosciences Oncology Drug Discovery Services Basic Information
9.18.2 HD Biosciences Oncology Drug Discovery Services Product Overview
9.18.3 HD Biosciences Oncology Drug Discovery Services Product Market Performance
9.18.4 HD Biosciences Business Overview
9.18.5 HD Biosciences Recent Developments
9.19 WuXi AppTec
9.19.1 WuXi AppTec Oncology Drug Discovery Services Basic Information
9.19.2 WuXi AppTec Oncology Drug Discovery Services Product Overview
9.19.3 WuXi AppTec Oncology Drug Discovery Services Product Market Performance
9.19.4 WuXi AppTec Business Overview
9.19.5 WuXi AppTec Recent Developments
10 Oncology Drug Discovery Services Market Forecast by Region
10.1 Global Oncology Drug Discovery Services Market Size Forecast
10.2 Global Oncology Drug Discovery Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Drug Discovery Services Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Drug Discovery Services Market Size Forecast by Region
10.2.4 South America Oncology Drug Discovery Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Drug Discovery Services by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oncology Drug Discovery Services Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Drug Discovery Services by Type (2025-2030)
11.1.2 Global Oncology Drug Discovery Services Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Drug Discovery Services by Type (2025-2030)
11.2 Global Oncology Drug Discovery Services Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Drug Discovery Services Sales (K Units) Forecast by Application
11.2.2 Global Oncology Drug Discovery Services Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings